Shilpa Medicare gets USFDA nod for cancer treatment injection

NEW DELHI: Shilpa Medicare Tuesday said it has received approval from the US health regulator for Irinotecan HCL injection, used for treatment of certain kind of cancers.

The company has received US Food and Drug Administration (USFDA) approval for its ANDA Irinotecan HCL injection USP in the strengths 40 mg/2mL and 100 mg/5mL (20mg/mL) single dose vials, Shilpa Medicare said in a BSE filing.

Irinotecan injection is used in the treatment of patients with metastatic carcinoma of the colon or rectum, the company added.

Quoting IQVIA MAT second quarter 2018 data, Shilpa Medicare said the US market for Irinotecan HCL is approximately USD 18 million.

Shares of Shilpa Medicare were trading 3.80 per cent up at Rs 398.65 apiece on BSE.

  • Related Posts

    Licences no shield in NDPS cases: HC refuses bail in 1.37 crore tablets seizure

    Justice Sumeet Goel made it clear that having licences or running a registered business did not automatically protect an accused, if the material on record pointed to possible illegal activity…

    No cough syrups without a doctor’s prescription – New rules announced

    The move comes months after at least 22 children died in Madhya Pradesh’s Chhindwara district after consuming contaminated cough syrups. Lozenges and pills, however, continue to be OTC The Union…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Yashoda Medicity’s AI-enabled E- ICU poised to make Quality Critical Care Universal

    Yashoda Medicity’s AI-enabled E- ICU poised to make Quality Critical Care Universal

    Licences no shield in NDPS cases: HC refuses bail in 1.37 crore tablets seizure

    Licences no shield in NDPS cases: HC refuses bail in 1.37 crore tablets seizure

    No cough syrups without a doctor’s prescription – New rules announced

    No cough syrups without a doctor’s prescription – New rules announced

    CSIR-IIIM launches two-month certificate course On cGMP-compliant herbal drug manufacturing

    CSIR-IIIM launches two-month certificate course On cGMP-compliant herbal drug manufacturing

    Two nurses at AIIMS Bhopal booked for giving wrong injection to child cancer patient that caused his death

    Two nurses at AIIMS Bhopal booked for giving wrong injection to child cancer patient that caused his death

    Telangana DCA unearths Rs 70.56-lakh excipient label-tampering scam

    Telangana DCA unearths Rs 70.56-lakh excipient label-tampering scam